17 December 2015 - The guidance seeks to assist sponsors of biosimilar medicines to complete an application to register their medicine on the ARTG while following the prescription medicines registration process and inform them of their ongoing responsibilities during the lifecycle of the medicine.

For more details, go to: http://www.tga.gov.au/publication/evaluation-biosimilars